Anika Therapeutics Inc (ANIK)
25.95
+0.69
(+2.73%)
USD |
NASDAQ |
May 10, 11:52
Anika Therapeutics Enterprise Value: 301.70M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 301.70M |
| May 08, 2024 | 349.30M |
| May 07, 2024 | 347.67M |
| May 06, 2024 | 340.26M |
| May 03, 2024 | 336.25M |
| May 02, 2024 | 336.25M |
| May 01, 2024 | 319.94M |
| April 30, 2024 | 311.04M |
| April 29, 2024 | 312.23M |
| April 26, 2024 | 306.30M |
| April 25, 2024 | 306.45M |
| April 24, 2024 | 311.19M |
| April 23, 2024 | 309.56M |
| April 22, 2024 | 311.93M |
| April 19, 2024 | 310.85M |
| April 18, 2024 | 304.77M |
| April 17, 2024 | 308.63M |
| April 16, 2024 | 305.95M |
| April 15, 2024 | 302.98M |
| April 12, 2024 | 298.38M |
| April 11, 2024 | 307.44M |
| April 10, 2024 | 311.15M |
| April 09, 2024 | 311.60M |
| April 08, 2024 | 306.70M |
| April 05, 2024 | 307.59M |
| Date | Value |
|---|---|
| April 04, 2024 | 313.38M |
| April 03, 2024 | 317.39M |
| April 02, 2024 | 310.71M |
| April 01, 2024 | 308.78M |
| March 28, 2024 | 304.32M |
| March 27, 2024 | 306.40M |
| March 26, 2024 | 303.73M |
| March 25, 2024 | 299.72M |
| March 22, 2024 | 305.21M |
| March 21, 2024 | 304.17M |
| March 20, 2024 | 307.14M |
| March 19, 2024 | 303.88M |
| March 18, 2024 | 302.39M |
| March 15, 2024 | 304.91M |
| March 14, 2024 | 291.55M |
| March 13, 2024 | 304.32M |
| March 12, 2024 | 310.11M |
| March 11, 2024 | 310.11M |
| March 08, 2024 | 304.62M |
| March 07, 2024 | 303.58M |
| March 06, 2024 | 313.68M |
| March 05, 2024 | 314.45M |
| March 04, 2024 | 308.44M |
| March 01, 2024 | 295.69M |
| February 29, 2024 | 283.08M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
132.14M
Minimum
Mar 18 2020
873.60M
Maximum
Oct 25 2019
386.59M
Average
376.25M
Median
May 15 2019
Enterprise Value Benchmarks
| The Cooper Companies Inc | 21.46B |
| Staar Surgical Co | 1.863B |
| OrthoPediatrics Corp | 761.19M |
| NexGel Inc | 12.49M |
| Innovative Eyewear Inc | -1.455M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -63.00M |
| Revenue (Quarterly) | 42.97M |
| Total Expenses (Quarterly) | 44.56M |
| EPS Diluted (Quarterly) | -4.30 |
| Gross Profit Margin (Quarterly) | 61.27% |
| Profit Margin (Quarterly) | -146.6% |
| Earnings Yield | -21.77% |
| Normalized Earnings Yield | -21.77 |